Oncologix Tech (OCLG) Financial Statements

10 Followers

Oncologix Tech Financial Overview

Oncologix Tech's market cap is currently $166.25K. The company's EPS TTM is $0; its P/E ratio is -0.03; Oncologix Tech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Aug 17
Income Statement
Total Revenue	$ 2.85M
Gross Profit	$ 571.56K
Operating Income	$ -865.00K
EBITDA	$ -1.11M
Net Income	$ -2.37M
Balance Sheet
Cash & Short-Term Investments	$ 30.83K
Total Assets	$ 1.50M
Total Debt	$ 5.16M
Net Debt	$ 5.12M
Total Liabilities	$ 7.47M
Stockholders' Equity	$ -5.97M
Cash Flow
Free Cash Flow	$ -25.12K
Operating Cash Flow	$ -24.20K
Investing Cash Flow	$ -913.00
Financing Cash Flow	$ -4.24K

Currency in USD

Oncologix Tech Earnings and Revenue History

Income Statement >

Oncologix Tech Debt to Assets

Balance Sheet >

Oncologix Tech Cash Flow

Cash Flow >

Oncologix Tech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >